These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35021421)

  • 21. PEGylated anti-MUC1 aptamer-doxorubicin complex for targeted drug delivery to MCF7 breast cancer cells.
    Tan L; Neoh KG; Kang ET; Choe WS; Su X
    Macromol Biosci; 2011 Oct; 11(10):1331-5. PubMed ID: 21818856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System.
    Yu T; Li Y; Gu X; Li Q
    Front Pharmacol; 2020; 11():532457. PubMed ID: 32982750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
    Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
    Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells.
    Debele TA; Yu LY; Yang CS; Shen YA; Lo CL
    Biomacromolecules; 2018 Sep; 19(9):3725-3737. PubMed ID: 30044910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional Bioconjugate for Cancer Cell-Targeted Theranostics.
    Du W; Yuan Y; Wang L; Cui Y; Wang H; Xu H; Liang G
    Bioconjug Chem; 2015 Dec; 26(12):2571-8. PubMed ID: 26580576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
    Alshaer W; Hillaireau H; Vergnaud J; Ismail S; Fattal E
    Bioconjug Chem; 2015 Jul; 26(7):1307-13. PubMed ID: 25343502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs.
    Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y
    Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo.
    Ghandhariyoun N; Jaafari MR; Nikoofal-Sahlabadi S; Taghdisi SM; Moosavian SA
    Life Sci; 2020 Dec; 262():118520. PubMed ID: 33010284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy.
    Gautam M; Thapa RK; Gupta B; Soe ZC; Ou W; Poudel K; Jin SG; Choi HG; Yong CS; Kim JO
    Expert Opin Drug Deliv; 2020 Mar; 17(3):423-434. PubMed ID: 32028805
    [No Abstract]   [Full Text] [Related]  

  • 33. Dual-targeting CD44 and mucin by hyaluronic acid and 5TR1 aptamer for epirubicin delivery into cancer cells: Synthesis, characterization,
    Jamshidi Z; Dehghan R; Nejabat M; Abnous K; Taghdisi SM; Hadizadeh F
    Heliyon; 2024 Jan; 10(2):e24833. PubMed ID: 38312665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor targeting using anti-her2 immunoliposomes.
    Park JW; Kirpotin DB; Hong K; Shalaby R; Shao Y; Nielsen UB; Marks JD; Papahadjopoulos D; Benz CC
    J Control Release; 2001 Jul; 74(1-3):95-113. PubMed ID: 11489487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical study of Doxorubicine-loaded liposomal drug delivery for the treatment of head and neck cancer: Optimization by Box-Behnken statistical design.
    Yang B
    Acta Biochim Pol; 2020 Jun; 67(2):149-155. PubMed ID: 32506868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression.
    Gao W; Lin Z; Chen M; Yang X; Cui Z; Zhang X; Yuan L; Zhang Q
    Int J Nanomedicine; 2014; 9():3425-37. PubMed ID: 25092974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aptamer-conjugated DNA nano-ring as the carrier of drug molecules.
    Srivithya V; Roun H; Sekhar Babu M; Jae Hyung P; Sung Ha P
    Nanotechnology; 2018 Mar; 29(9):095602. PubMed ID: 29271356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
    Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
    PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer.
    Atabi F; Mousavi Gargari SL; Hashemi M; Yaghmaei P
    Iran J Pharm Res; 2017; 16(1):35-49. PubMed ID: 28496460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.